Access in South Africa

Sub-Saharan Africa ยท Tier 2

Regulatory framework

South Africa's SAHPRA operates a Section 21 named-patient pathway widely used for unregistered specialty drugs.

Case active and ready to skip the regulatory walkthrough? Start your case or WhatsApp us.

Typical timeline

For patients in South Africa requesting a specialty drug through Reserve Meds, the end-to-end timeline from initial request to drug delivery typically ranges 2-8 weeks. Timing depends on the specific drug, the clinical justification, and destination-regulator review pace.

What a typical process looks like

  1. Patient or physician submits a request with drug name and indication.
  2. We verify clinical appropriateness and document eligibility.
  3. Treating physician issues prescription and clinical justification.
  4. Country-specific regulatory documentation is prepared and submitted.
  5. Patient pre-pays; we source via DSCSA-compliant US wholesaler.
  6. Drug ships cold-chain to destination physician or hospital pharmacy.
  7. Physician receives, confirms storage, and begins treatment.

Popular drug requests from South Africa

Lenmeldy

Metachromatic leukodystrophy

Kresladi

Leukocyte adhesion deficiency I

Elevidys

Duchenne muscular dystrophy

Lyfgenia

Sickle cell disease

Zevaskyn

Recessive DEB

Skysona

Cerebral adrenoleukodystrophy

Casgevy

Sickle cell disease; transfusion-dependent beta-thalassemia

Ryoncil

Pediatric SR-aGvHD

Tecelra

Synovial sarcoma

Encelto

Macular telangiectasia type 2

Qfitlia

Hemophilia A/B prophylaxis

Vyjuvek

Dystrophic epidermolysis bullosa

Review & oversight. Content on this page is reviewed by Reserve Meds's clinical and regulatory team. A US-licensed pharmacist reviews every prescription before dispensing. Regulatory posture is informational, not legal advice; case-specific questions route to retained outside counsel. Review methodology ›
Last medically reviewed: .
WhatsApp